Cargando…

Multigene tests for breast cancer: the physician’s perspective

Breast cancer is the most common tumour in women and the first cause of death for cancer in the female population. Preserving the quality of life has therefore become an important objective in the management of the disease. The benefits of adjuvant chemotherapy in patients with HR+ HER2- early breas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cognetti, Francesco, Biganzoli, Laura, De Placido, Sabino, del Mastro, Lucia, Masetti, Riccardo, Naso, Giuseppe, Pruneri, Giancarlo, Santini, Donatella, Tondini, Carlo Alberto, Tinterri, Corrado, Tonini, Giuseppe, Barni, Sandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092339/ https://www.ncbi.nlm.nih.gov/pubmed/33953847 http://dx.doi.org/10.18632/oncotarget.27948

Ejemplares similares

PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
por: Cognetti, Francesco, et al.
Publicado: (2021)

Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group
por: Licata, Luca, et al.
Publicado: (2023)

The clinician’s perspective on the 21-gene assay in early breast cancer
por: Cognetti, Francesco, et al.
Publicado: (2021)

Can multigene assays widen their clinical usefulness in early breast cancer treatment choice during the current COVID-19 outbreak in Italy?
por: Zambelli, Alberto, et al.
Publicado: (2020)

NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy
por: Tinterri, Corrado, et al.
Publicado: (2019)

Brief letter of a doctor to his psychologist in the COVID-19 outbreak era
por: Santini, Daniele, et al.
Publicado: (2020)

Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM)
por: Dieci, Maria Vittoria, et al.
Publicado: (2019)

Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
por: Puglisi, Fabio, et al.
Publicado: (2021)

The central role of pathology labs in breast cancer precision oncology: a call for action
por: Pruneri, Giancarlo, et al.
Publicado: (2023)

Author response to: Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study
por: Gentile, Damiano, et al.
Publicado: (2023)

First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
por: Tonini, Giuseppe, et al.
Publicado: (2009)

Evolution and variation of multigene families
por: Ohta, Tomoko
Publicado: (1980)

Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer
por: Belardinilli, Francesca, et al.
Publicado: (2020)

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
por: Del Mastro, Lucia, et al.
Publicado: (2013)

Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Response to: Successful afatinib rechallenge in a patient with non‐small cell lung cancer harboring EGFR G719C and S768I mutations
por: Citarella, Fabrizio, et al.
Publicado: (2021)

Targeting bone metastases starting from the preneoplastic niche: home sweet home
por: Santini, Daniele, et al.
Publicado: (2011)

The ‘Charter of Rights for Family Caregivers’. The role and importance of the caregiver: an Italian proposal
por: Antonella, Sisto, et al.
Publicado: (2017)

Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib
por: Manca, Paolo, et al.
Publicado: (2017)

Coronavirus Disease 2019 or Lung Cancer: What Should We Treat?
por: Russano, Marco, et al.
Publicado: (2020)

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
por: Simbolo, Michele, et al.
Publicado: (2014)

Broadly sampled multigene trees of eukaryotes
por: Yoon, Hwan Su, et al.
Publicado: (2008)

Multigene Phylogeny of Choanozoa and the Origin of Animals
por: Shalchian-Tabrizi, Kamran, et al.
Publicado: (2008)

The actin multigene family of Paramecium tetraurelia
por: Sehring, Ivonne M, et al.
Publicado: (2007)

LMAP: Lightweight Multigene Analyses in PAML
por: Maldonado, Emanuel, et al.
Publicado: (2016)

New insights on multigenic autoinflammatory diseases
por: Efthimiou, Petros, et al.
Publicado: (2022)

An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
por: Lazzaro, Carlo, et al.
Publicado: (2013)

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
por: Curigliano, Giuseppe, et al.
Publicado: (2023)

Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
por: Tonini, Giuseppe, et al.
Publicado: (2013)

Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review
por: Garutti, Mattia, et al.
Publicado: (2022)

Biología marina /
por: Cognetti, Giuseppe, 1928-
Publicado: (2001)

Optimizing checkpoint inhibitors therapy for relapsed or progressive classic Hodgkin lymphoma by multiplex immunohistochemistry of the tumor microenvironment
por: Carbone, Antonino, et al.
Publicado: (2019)

The evolving landscape in advanced penile cancer
por: Buonerba, Carlo, et al.
Publicado: (2015)

Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families
por: Coppa, Anna, et al.
Publicado: (2017)

Gene Expression Profiling via Multigene Concatemers
por: Jin, Kai, et al.
Publicado: (2011)

The UDP-glucosyltransferase multigene family in Bombyx mori
por: Huang, Fei-Fei, et al.
Publicado: (2008)

Multigene phylogeny, taxonomy and reclassification of Hyaloperonospora on Cardamine
por: Voglmayr, Hermann, et al.
Publicado: (2013)

Disentangling the multigenic and pleiotropic nature of molecular function
por: Stoney, Ruth A, et al.
Publicado: (2015)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

An Overview of The Globozoospermia as A Multigenic Identified Syndrome
por: Modarres, Parastoo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5k1kto2e668iff7816694qovic